What does X4 Pharmaceuticals, Inc. do?

Jun 22 2025 07:05 PM IST
share
Share Via
X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for rare diseases, including primary immunodeficiencies and cancer. As of March 2025, it has a market cap of $15.86 million and reported net sales of $29 million with no net profit.
Overview:
X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare diseases, including primary immunodeficiencies and cancer, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 29 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: 0 Million (Quarterly Results - Mar 2025)
Market-cap: USD 15.86 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.44
Return on Equity: -46.83%
Price to Book: 0.69

Contact Details:
Address: 61 NORTH BEACON STREET, 4TH FLOOR, BOSTON MA : 02134
Tel: ['1 857 5298300', '1 875 3411043']
Fax: 1 302 6555049
Website: http://www.x4pharma.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is X4 Pharmaceuticals, Inc. technically bullish or bearish?
Sep 20 2025 08:07 PM IST
share
Share Via
Is X4 Pharmaceuticals, Inc. overvalued or undervalued?
Sep 20 2025 06:40 PM IST
share
Share Via
Is X4 Pharmaceuticals, Inc. overvalued or undervalued?
Jun 25 2025 09:21 AM IST
share
Share Via
Is X4 Pharmaceuticals, Inc. technically bullish or bearish?
Jun 25 2025 09:06 AM IST
share
Share Via
Who are in the management team of X4 Pharmaceuticals, Inc.?
Jun 22 2025 10:44 PM IST
share
Share Via
How big is X4 Pharmaceuticals, Inc.?
Jun 22 2025 06:16 PM IST
share
Share Via